The U.S. Food and Drug Administration and a panel of its outside advisers have expressed concerns over Pfizer’s “unblinding” plan, saying it could make it harder to continue collecting data on safety and effectiveness needed to win full FDA approval of the vaccine.
from Top World News- News18.com https://ift.tt/3pB7vgU
Subscribe to:
Post Comments (Atom)
-
The Doha accord would see thousands of American troops quit Afghanistan in a phased plan after more than 18 years in return for various secu...
-
A mysterious dissident group accused of breaking into the North Korea's embassy in Madrid last month said on Thursday it was temporarily...
-
The launch on Monday came two days North Korea's state media said leader Kim Jong Un supervised an artillery drill aimed at testing the ...
No comments:
Post a Comment